Briobacept

Tax included
Briobacept (BR 3FC) is a selective human monoclonal antibody targeting to BLyS (BAFF), induces B cells apoptosis. Briobacept is a recombinant glucoprotein, consists of 2 molecules from the BLyS receptor (BR3)and a Fc domain of human IgG1. Briobacept can be used in studies of rheumatoid arthritis (RA).
MedChemExpress 
HY-P99487

Data sheet

Size
Multiple sizes
Reactivity
ADC Antibody
Application
COVID-19-immunoregulation
CAS
869881-54-9